Nasdaq

Teleflex Incorporated Reports Positive Clinical Data for UroLift™ System at AUA 2025, Highlighting Improved Patient Satisfaction and Outcomes for BPH Treatment

Teleflex Incorporated presented new clinical data at the 2025 American Urological Association Annual Meeting, highlighting the UroLift™ System as a leading minimally invasive treatment for benign ...
Hosted on MSN

How UroLift surgery offers prostate patients hope, less erectile damage risk

UroLift is a minimally invasive treatment for Benign Prostatic Hyperplasia, a condition that causes an enlarged prostate in men. The procedure uses tiny implants to lift and hold the enlarged prostate ...
Nasdaq

Teleflex Incorporated Reports Positive Findings from CLEAR Study on UroLift™ System at EAU Congress 2025

Teleflex announces favorable results for UroLift™ in treating BPH, showing higher patient satisfaction and better early recovery compared to Rezūm. Teleflex Incorporated announced new results from the ...